GLENMARK.NS - Glenmark Pharmaceuticals Limited

NSE - NSE Real Time Price. Currency in INR

Glenmark Pharmaceuticals Limited

Glenmark House
B.D. Sawant Marg Chakala, Off Western Express Highway Andheri (East)
Mumbai 400099
91 22 4018 9999

IndustryDrugs - Generic
Full Time Employees13,000

Key Executives

Mr. Glenn Mario SaldanhaChairman, MD & CEO141MN/A47
Mr. Harish KuberCompany Sec. & Compliance Officer390kN/AN/A
Mrs. Cherylann Maria Pinto B.PharmDirector of Corp. Affairs & Exec. Director38.76MN/A50
Mr. V. S. ManiPres & Global CFON/AN/A52
Dr. Fred Grossman D.O., FAPAPres & Chief Medical OfficerN/AN/AN/A
Amounts are as of December 31, 2017 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in INR.


Glenmark Pharmaceuticals Limited, together with its subsidiaries, develops, manufactures, and markets pharmaceutical products in India, the United States, Latin America, Europe, and internationally. The company provides branded and generic formulations in therapeutic areas of dermatology, respiratory, and oncology; and various active pharmaceutical ingredients. Its products under development comprise GBR 1302 for breast and gastric cancer; GBR 1342 for multiple myeloma; GBR 1372 for colorectal cancer; GBR 8383 for multiple cancers; GBR 830 for atopic dermatitis; GRC 39815 for COPD and IPF; GSP 301 for allergic rhinitis; GSP 304 for COPD; GBR 310 for Asthma and CIU; and GRC 27864 for chronic pain indications. The company was founded in 1977 and is based in Mumbai, India.

Corporate Governance

Glenmark Pharmaceuticals Limited’s ISS Governance QualityScore as of February 1, 2018 is 5. The pillar scores are Audit: 9; Board: 7; Shareholder Rights: 1; Compensation: 7.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.